Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Medtronic
Teva
Cantor Fitzgerald
Accenture
UBS
Chubb
US Army
Moodys

Generated: November 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,115,564

« Back to Dashboard

Title:Stable pharmaceutical compositions of dalbavancin and methods of administration
Abstract: The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
Inventor(s): Cavaleri; Marco (Saronno, IT), Jabes; Daniela (Cassina Rizzardi, IT), Henkel; Timothy (Berwyn, PA), Malabarba; Adriano (Buccinasco, IT), Mosconi; Giorgio (Malvern, PA), Stogniew; Martin (Blue Bell, PA), White; Richard J. (Emeryville, CA)
Assignee: Vicuron Pharmaceuticals, Inc. (King of Prussia, PA)
Filing Date:Apr 16, 2004
Application Number:10/828,439
Claims:1. A stabilized dry dosage form for reconstitution comprising: dalbavancin; an effective stabilizer comprising mannitol and lactose; wherein the pH of the dosage form is about 3 to about 5.

2. The dosage form of claim 1, wherein the weight ratio of mannitol to lactose to dalbavancin is about 1:1:4.

3. The dosage form of claim 1, wherein the pH is about 3.5 to about 4.5.

4. The dosage form of claim 1, wherein the pH is about 4.5.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Harvard Business School
UBS
Chubb
Johnson and Johnson
Farmers Insurance
US Army
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.